Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Abnormal Glucose Tolerance”

19 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 19 results

Testing effectiveness (Phase 2)UnknownNCT01364155
What this trial is testing

Safety, Tolerability, PK, and PD of LIM-0705 in Subjects With Impaired Glucose Tolerance or Abnormal HOMA-IR

Who this might be right for
Impaired Glucose ToleranceInsulin Resistance
Limerick BioPharma 50
Post-approval studies (Phase 4)UnknownNCT00858676
What this trial is testing

Impact of Acarbose on Abnormal Glucose Regulation in Patients With Coronary Artery Disease (AAA Trial)

Who this might be right for
Diabetes MellitusImpaired Glucose ToleranceCoronary Artery Disease
Aichi Gakuin University 150
Not applicableStudy completedNCT03659461
What this trial is testing

Glucagon-like Peptide-1 Levels, Insulin Resistance and Insulin Sensitivity Index in Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes MellitusPreDiabetes
National University of Malaysia 174
Not applicableStudy completedNCT04503408
What this trial is testing

A Comparison of Clinical Parameters in With and Without Abnormal Glucose Tolerance.

Who this might be right for
Cystic Fibrosis-related DiabetesDiabetes MellitusCystic Fibrosis
Hacettepe University 40
Testing effectiveness (Phase 2)Ended earlyNCT02955888
What this trial is testing

Study of Safety, Tolerability & Efficacy in Cystic Fibrosis Patients With Abnormal Glucose Tolerance

Who this might be right for
Cystic Fibrosis
Liminal BioSciences Ltd. 11
Testing effectiveness (Phase 2)Looking for participantsNCT04731272
What this trial is testing

GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance

Who this might be right for
Cystic FibrosisPancreatic InsufficiencyAbnormal Glucose Tolerance+1 more
University of Pennsylvania 30
Not applicableUnknownNCT04490460
What this trial is testing

Effects on Glycemic Control of WBF-0031 in Subjects With Abnormal Glucose Tolerance

Who this might be right for
Abnormal Glucose Tolerance
Eden Miller 30
Not applicableNot Yet RecruitingNCT06704542
What this trial is testing

Abnormal Glucose Tolerance in Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATIONDiabetes MellitusImpaired Fasting Glucose
Ruijin Hospital 1,000
Testing effectiveness (Phase 2)Ended earlyNCT03428945
What this trial is testing

Hydroxychloroquine in Individuals At-risk for Type 1 Diabetes Mellitus

Who this might be right for
Type1 Diabetes Mellitus
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 273
Testing effectiveness (Phase 2)Study completedNCT00573781
What this trial is testing

Dietary Modulation of Gene Expression and Metabolic Pathways in Glucose Metabolism

Who this might be right for
Metabolic SyndromeObesityImpaired Glucose Tolerance+1 more
Marjukka Kolehmainen 106
Not applicableStudy completedNCT01839448
What this trial is testing

Abnormal Post-partum Glucose Metabolism After Gestational Diabetes Diagnosed Before or After 24 Weeks of Gestation

Who this might be right for
Gestational DiabetesType 2 DiabetesGlucose Intolerance
Centre Hospitalier Universitaire de Nīmes 500
Testing effectiveness (Phase 2)Study completedNCT01773707
What this trial is testing

CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1

Who this might be right for
Abnormal Glucose ToleranceType 1 Diabetes
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 212
Not applicableWithdrawnNCT00786175
What this trial is testing

A Survey to Evaluate the Rate of Abnormal Glucose Tolerance Among Hong Kong Chinese Subjects With Coronary Heart Disease

Who this might be right for
Coronary Heart DiseaseDiabetes Mellitus
Chinese University of Hong Kong
Not applicableStudy completedNCT05705609
What this trial is testing

The Effect of Mandala Art Therapy on Pregnant Women With Abnormal OGTT

Who this might be right for
Pregnancy Related
Inonu University 68
Large-scale testing (Phase 3)Study completedNCT00221156
What this trial is testing

Acarbose and Secondary Prevention After Coronary Stenting

Who this might be right for
Glucose Metabolism DisordersCoronary Artery Disease
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 300
Large-scale testing (Phase 3)Study completedNCT04599465
What this trial is testing

Assess the Effect of ELX/TEZ/IVA on Glucose Tolerance in Participants With Cystic Fibrosis (CF)

Who this might be right for
Cystic Fibrosis
Vertex Pharmaceuticals Incorporated 69
Post-approval studies (Phase 4)UnknownNCT02502344
What this trial is testing

Effect of Medical Interventions in Insulin Resistance on Prevalence of Abnormal Glucose Tolerance

Who this might be right for
Insulin Resistance
Beijing Tsinghua Chang Gung Hospital 60
Not applicableStudy completedNCT03650712
What this trial is testing

EnVision CF Multicenter Study of Glucose Tolerance in Cystic Fibrosis

Who this might be right for
Cystic Fibrosis-related Diabetes
Katie Larson Ode 317
Not applicableUnknownNCT02440217
What this trial is testing

Myocardial Metabolism in Patients With Dilated Cardiomyopathy

Who this might be right for
Dilated CardiomyopathyType 2 Diabetes
Azienda Ospedaliero, Universitaria Pisana 15